Market Overview:
The global testosterone replacement therapy market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of low testosterone levels, rising awareness about the benefits of testosterone replacement therapy, and growing demand for better treatment options for various medical conditions. The global testosterone replacement therapy market is segmented on the basis of type into gels, injections, patches, and other products. The gel segment is expected to account for the largest share of the market in 2018 owing to its high popularity among patients owing to its ease of use and convenience. However, the injection segment is projected to grow at a higher CAGR during the forecast period due its advantages over other forms such as gels and patches. On the basis of application, hospitals are expected account for majority share in 2018 followed by clinics.
Product Definition:
Testosterone Replacement Therapy is a form of hormone therapy used to treat men with low testosterone levels. Testosterone is a hormone that plays an important role in the development of male reproductive tissues such as the testes and prostate, as well as promoting secondary sex characteristics such as muscle mass and beard growth. Testosterone levels naturally decline with age, but some men may experience a more significant decline due to certain health conditions or medications. Symptoms of low testosterone can include decreased libido, fatigue, mood changes, and reduced muscle mass and strength. Testosterone Replacement Therapy can help restore normal testosterone levels and improve symptoms related to low testosterone.
Gels:
Gels are clear, water-based emulsions that comprise of around 25% concentration of the active ingredient. They are usually applied to the affected area and massaged in for better absorption. The gels can be administered directly into the vein or they can be applied with a syringe and then injected into the body.
Injections:
Injections are the most common form of testosterone replacement therapy (TRT). In this therapy, a physician will prescribe an injection of testosterone to raise levels in the body. The FDA has approved four types of injectable drugs for TRT: AndroGel, Testim, Aranesp and Synthol-Sulphonylurea.
According to studies conducted by researchers at Boston University School of Law in collaboration with Pfizer Inc.
Application Insights:
The others application segment held the largest share of more than 50.0% in 2017. Other applications include testosterone replacement therapy at home, which is mainly used by men above 40 years of age who cannot afford expensive treatment at hospitals or clinics. Testosterone replacement therapy products are also available directly to consumers through online pharmacies, a practice that is illegal in many countries including the U.S., Canada and Australia due to lack of regulatory framework governing these practices. Home delivery services are expected to be one of the major revenue-generating strategies for market players during the forecast period as it offers several advantages such as convenience and flexibility along with an opportunity for patients to adjust dosage according to their requirements without visiting doctors or medical institutions frequently.
Regional Analysis:
North America dominated the global market in 2017 owing to an increase in the prevalence of low testosterone levels among men. In addition, rising awareness about various treatment options and increasing R&D activities for development of novel therapies are some other factors driving this regional market. The U.S., being a developed economy, has a high penetration rate for these therapies due to its advanced healthcare infrastructure and facilities compared to developing countries from Asia Pacific region which is expected to drive this regional market over the forecast period.
Growth Factors:
- Increasing awareness about the benefits of testosterone replacement therapy (TRT) is driving the market growth.
- Growing geriatric population is also a major factor that is contributing to the growth of TRT market.
- Rising prevalence of testosterone deficiency syndrome (TDS) is also propelling the demand for TRT products and services worldwide.
- Increasing investment by key players in research and development activities for new TRT products is another major factor fuelling market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Testosterone Replacement Therapy Market Research Report
By Type
Gels, Injections, Patches, Other
By Application
Hospitals, Clinics, Others
By Companies
AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
129
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Testosterone Replacement Therapy Market Report Segments:
The global Testosterone Replacement Therapy market is segmented on the basis of:
Types
Gels, Injections, Patches, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie
- Endo International
- Eli lilly
- Pfizer
- Actavis (Allergan)
- Bayer
- Novartis
- Teva
- Mylan
- Upsher-Smith
- Ferring Pharmaceuticals
- Kyowa Kirin
- Acerus Pharmaceuticals
Highlights of The Testosterone Replacement Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gels
- Injections
- Patches
- Other
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Testosterone Replacement Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Testosterone replacement therapy is a treatment for low testosterone levels in men. Testosterone replacement therapy can help to improve symptoms such as fatigue, loss of muscle mass, reduced sex drive, and erectile dysfunction. Testosterone replacement therapy can also help to increase bone density and decrease the risk of prostate cancer.
Some of the major players in the testosterone replacement therapy market are AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals.
The testosterone replacement therapy market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Testosterone Replacement Therapy Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Testosterone Replacement Therapy Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Testosterone Replacement Therapy Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Testosterone Replacement Therapy Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Testosterone Replacement Therapy Market Size & Forecast, 2020-2028 4.5.1 Testosterone Replacement Therapy Market Size and Y-o-Y Growth 4.5.2 Testosterone Replacement Therapy Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Gels
5.2.2 Injections
5.2.3 Patches
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Testosterone Replacement Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Testosterone Replacement Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Gels
9.6.2 Injections
9.6.3 Patches
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Gels
10.6.2 Injections
10.6.3 Patches
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Gels
11.6.2 Injections
11.6.3 Patches
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Gels
12.6.2 Injections
12.6.3 Patches
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Gels
13.6.2 Injections
13.6.3 Patches
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Testosterone Replacement Therapy Market: Competitive Dashboard
14.2 Global Testosterone Replacement Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie
14.3.2 Endo International
14.3.3 Eli lilly
14.3.4 Pfizer
14.3.5 Actavis (Allergan)
14.3.6 Bayer
14.3.7 Novartis
14.3.8 Teva
14.3.9 Mylan
14.3.10 Upsher-Smith
14.3.11 Ferring Pharmaceuticals
14.3.12 Kyowa Kirin
14.3.13 Acerus Pharmaceuticals